UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 175

Sortiert nach

Cognitive change trajectories in virally suppressed HIV-infected individuals indicate high prevalence of disease activity

PloS one, 2017-03, Vol.12 (3), p.e0171887-e0171887

2017

Link zum Volltext

Verfügbarkeit prüfen

HIV-Associated Neurocognitive Disorders: A Global Perspective

Journal of the International Neuropsychological Society, 2017-10, Vol.23 (9-10), p.860-869

2017

Link zum Volltext

Verfügbarkeit prüfen

Vascular cognitive impairment and HIV-associated neurocognitive disorder: a new paradigm

Journal of neurovirology, 2019-10, Vol.25 (5), p.710-721

2019

Link zum Volltext

Verfügbarkeit prüfen

Is neurocognitive ageing accelerated in virally suppressed people with HIV and multimorbidity?

Brain (London, England : 1878), 2023-03, Vol.146 (3), p.801-802

2023

Link zum Volltext

Verfügbarkeit prüfen

Identifying Neurocognitive Decline at 36 Months among HIV-Positive Participants in the CHARTER Cohort Using Group-Based Trajectory Analysis

PloS one, 2016-05, Vol.11 (5), p.e0155766-e0155766

2016

Link zum Volltext

Verfügbarkeit prüfen

Comprehensive clinical assessment identifies specific neurocognitive deficits in working-age patients with long-COVID

PloS one, 2022-06, Vol.17 (6), p.e0267392-e0267392

2022

Link zum Volltext

Verfügbarkeit prüfen

Brain aging and cardiovascular factors in HIV: a longitudinal volume and shape MRI study

AIDS (London), 2022-05, Vol.36 (6), p.785-794

2022

Link zum Volltext

Verfügbarkeit prüfen

A Screening Strategy for HIV-Associated Neurocognitive Disorders That Accurately Identifies Patients Requiring Neurological Review

Clinical infectious diseases, 2016-09, Vol.63 (5), p.687-693

2016

Link zum Volltext

Verfügbarkeit prüfen

Socioeconomic factors explain suboptimal adherence to antiretroviral therapy among HIV-infected Australian adults with viral suppression

PloS one, 2017-04, Vol.12 (4), p.e0174613-e0174613

2017

Link zum Volltext

Verfügbarkeit prüfen

Neuropsychological Functioning and Antiretroviral Treatment in HIV/AIDS: A Review

Neuropsychology review, 2009-06, Vol.19 (2), p.169-185

2009

Link zum Volltext

Verfügbarkeit prüfen

Maraviroc-intensified combined antiretroviral therapy improves cognition in virally suppressed HIV-associated neurocognitive disorder

AIDS (London), 2016-02, Vol.30 (4), p.591-600

2016

Link zum Volltext

Verfügbarkeit prüfen

Concomitant medication polypharmacy, interactions and imperfect adherence are common in Australian adults on suppressive antiretroviral therapy

AIDS (London), 2018-01, Vol.32 (1), p.35-48

2018

Link zum Volltext

Verfügbarkeit prüfen

Peripheral blood mononuclear cells HIV DNA levels impact intermittently on neurocognition

PloS one, 2015-04, Vol.10 (4), p.e0120488-e0120488

2015

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of non-confounded HIV-associated neurocognitive impairment in the context of plasma HIV RNA suppression

Journal of neurovirology, 2011-04, Vol.17 (2), p.176-183

2011

Link zum Volltext

Verfügbarkeit prüfen

HIV, Vascular and Aging Injuries in the Brain of Clinically Stable HIV-Infected Adults: A 1H MRS Study

PloS one, 2013-04, Vol.8 (4), p.e61738

2013

Link zum Volltext

Verfügbarkeit prüfen

The Chronicity of HIV Infection Should Drive the Research Strategy of NeuroHIV Treatment Studies: A Critical Review

CNS drugs, 2016-01, Vol.30 (1), p.53-69

2016

Link zum Volltext

Verfügbarkeit prüfen

Central nervous system antiretroviral efficacy in HIV infection: a qualitative and quantitative review and implications for future research

BMC neurology, 2011-11, Vol.11 (1), p.148-148, Article 148

2011

Link zum Volltext

Verfügbarkeit prüfen

The comorbidity of depression and neurocognitive disorder in persons with HIV infection: call for investigation and treatment

Frontiers in cellular neuroscience, 2023-04, Vol.17, p.1130938-1130938

2023

Link zum Volltext

Verfügbarkeit prüfen

HIV, vascular and aging injuries in the brain of clinically stable HIV-infected adults: a (1)H MRS study

PloS one, 2013, Vol.8 (4), p.e61738-e61738

2013

Link zum Volltext

Verfügbarkeit prüfen

Could excess body weight be good for cognitive health in chronic HIV infection?

Neurology, 2019-07, Vol.93 (3), p.95

2019

Link zum Volltext

Verfügbarkeit prüfen

High prevalence of neurocognitive disorders observed among adult people living with HIV/AIDS in Southern Ethiopia: A cross-sectional study

PloS one, 2019-03, Vol.14 (3), p.e0204636-e0204636

2019

Link zum Volltext

Verfügbarkeit prüfen

Is There Any Evidence of Premature, Accentuated and Accelerated Aging Effects on Neurocognition in People Living with HIV? A Systematic Review

AIDS and behavior, 2021-03, Vol.25 (3), p.917-960

2021

Link zum Volltext

Verfügbarkeit prüfen

Neurocognitive Complications of HIV-Infection: Neuropathogenesis to Implications for Clinical Practice

1st Edition 2021, 2021

Link zum Volltext

Verfügbarkeit prüfen

Asymptomatic neurocognitive impairment is a risk for symptomatic decline over a 3-year study period

AIDS (London), 2021-01, Vol.35 (1), p.63-72

2021

Link zum Volltext

Verfügbarkeit prüfen

Elevation of cell-associated HIV-1 transcripts in CSF CD4+ T cells, despite effective antiretroviral therapy, is linked to brain injury

Proceedings of the National Academy of Sciences - PNAS, 2022-11, Vol.119 (48), p.e2210584119

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 175

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(145)
Mit Volltextzugriff
(157)

Publikationsform

Sprache

Englisch
(175)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Cognitive change trajectories in virally suppressed HIV-infected individuals indicate high prevalence of disease activity

HIV-Associated Neurocognitive Disorders: A Global Perspective

Vascular cognitive impairment and HIV-associated neurocognitive disorder: a new paradigm

Is neurocognitive ageing accelerated in virally suppressed people with HIV and multimorbidity?

Identifying Neurocognitive Decline at 36 Months among HIV-Positive Participants in the CHARTER Cohort Using Group-Based Trajectory Analysis

Comprehensive clinical assessment identifies specific neurocognitive deficits in working-age patients with long-COVID

Brain aging and cardiovascular factors in HIV: a longitudinal volume and shape MRI study

A Screening Strategy for HIV-Associated Neurocognitive Disorders That Accurately Identifies Patients Requiring Neurological Review

Socioeconomic factors explain suboptimal adherence to antiretroviral therapy among HIV-infected Australian adults with viral suppression

Neuropsychological Functioning and Antiretroviral Treatment in HIV/AIDS: A Review

Maraviroc-intensified combined antiretroviral therapy improves cognition in virally suppressed HIV-associated neurocognitive disorder

Concomitant medication polypharmacy, interactions and imperfect adherence are common in Australian adults on suppressive antiretroviral therapy

Peripheral blood mononuclear cells HIV DNA levels impact intermittently on neurocognition

Prevalence of non-confounded HIV-associated neurocognitive impairment in the context of plasma HIV RNA suppression

HIV, Vascular and Aging Injuries in the Brain of Clinically Stable HIV-Infected Adults: A 1H MRS Study

The Chronicity of HIV Infection Should Drive the Research Strategy of NeuroHIV Treatment Studies: A Critical Review

Central nervous system antiretroviral efficacy in HIV infection: a qualitative and quantitative review and implications for future research

The comorbidity of depression and neurocognitive disorder in persons with HIV infection: call for investigation and treatment

HIV, vascular and aging injuries in the brain of clinically stable HIV-infected adults: a (1)H MRS study

Could excess body weight be good for cognitive health in chronic HIV infection?

High prevalence of neurocognitive disorders observed among adult people living with HIV/AIDS in Southern Ethiopia: A cross-sectional study

Is There Any Evidence of Premature, Accentuated and Accelerated Aging Effects on Neurocognition in People Living with HIV? A Systematic Review

Neurocognitive Complications of HIV-Infection: Neuropathogenesis to Implications for Clinical Practice

Asymptomatic neurocognitive impairment is a risk for symptomatic decline over a 3-year study period

Elevation of cell-associated HIV-1 transcripts in CSF CD4+ T cells, despite effective antiretroviral therapy, is linked to brain injury

Suchergebnisse filtern